share_log

JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $22

JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $22

JMP證券維持Ocular Therapeutix的市場跑贏大盤,將目標股價下調至22美元
Benzinga ·  05/08 14:08

JMP Securities analyst Jonathan Wolleben maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and lowers the price target from $24 to $22.

JMP證券分析師喬納森·沃勒本維持Ocular Therapeutix(納斯達克股票代碼:OCUL)的市場表現跑贏大盤,並將目標股價從24美元下調至22美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論